These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 24453094)

  • 1. Why and when should we worry about worsening renal function?
    Damman K; McMurray JJ
    Eur J Heart Fail; 2014 Jan; 16(1):4-5. PubMed ID: 24453094
    [No Abstract]   [Full Text] [Related]  

  • 2. Worsening renal function during renin-angiotensin-aldosterone system inhibitor initiation and long-term outcomes in patients with left ventricular systolic dysfunction.
    Clark H; Krum H; Hopper I
    Eur J Heart Fail; 2014 Jan; 16(1):41-8. PubMed ID: 24453097
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Therapy of heart failure with angiotensin converting enzyme inhibitors. Effects on renal function].
    Osterziel KJ; Dietz R; Kübler W
    Dtsch Med Wochenschr; 1989 Jul; 114(27):1082-5. PubMed ID: 2661192
    [No Abstract]   [Full Text] [Related]  

  • 4. Concern for azotemia with angiotensin-converting enzyme inhibitors: public health implications and clinical relevance.
    Bart BA
    Am Heart J; 1999 Nov; 138(5 Pt 1):801-3. PubMed ID: 10539807
    [No Abstract]   [Full Text] [Related]  

  • 5. [Angiotensin-converting enzyme inhibitors. Principles and rules of their use].
    Juillière Y
    Rev Prat; 2001 Sep; 51(14):1601-7. PubMed ID: 11757278
    [No Abstract]   [Full Text] [Related]  

  • 6. Addition of vitamin D reverses the decline in GFR following treatment with ACE inhibitors/angiotensin receptor blockers in patients with chronic kidney disease.
    Soares AE; Maes M; Godeny P; Matsumoto AK; Barbosa DS; da Silva TAF; Souza FHMO; Delfino VDA
    Life Sci; 2017 Dec; 191():175-179. PubMed ID: 29079468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acute change in glomerular filtration rate with inhibition of the renin-angiotensin system does not predict subsequent renal and cardiovascular outcomes.
    Clase CM; Barzilay J; Gao P; Smyth A; Schmieder RE; Tobe S; Teo KK; Yusuf S; Mann JF
    Kidney Int; 2017 Mar; 91(3):683-690. PubMed ID: 27927602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renin-angiotensin blockade and kidney disease.
    Sarafidis PA; Bakris GL
    Lancet; 2008 Aug; 372(9638):511-2. PubMed ID: 18707969
    [No Abstract]   [Full Text] [Related]  

  • 9. Renin-angiotensin inhibitors in stage 4 chronic kidney disease.
    Hirsch S
    Kidney Int; 2006 Nov; 70(10):1880; author reply 1880-1. PubMed ID: 17080165
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and hemodynamic effects of renin-angiotensin system blockade in cardiac transplant recipients.
    Karabsheh S; Verma DR; Jain M; Stoddard G; Brunisholz K; Stehlik J; Kfoury A; Gilbert E; Bader F
    Am J Cardiol; 2011 Dec; 108(12):1836-9. PubMed ID: 22133132
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of dietary factors on the renal renin-angiotensin system.
    Wagner J; Stein G; Mann J; Ritz E
    Klin Wochenschr; 1992; 69 Suppl 29():35-8. PubMed ID: 1614190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Conservative management of chronic kidney disease stage 5: role of angiotensin converting enzyme inhibitors.
    Dattolo PC; Gallo P; Michelassi S; Paudice N; Cannavò R; Romoli E; Fani F; Tsalouchos A; Mehmetaj A; Ferro G; Sisca S; Pizzarelli F
    J Nephrol; 2016 Dec; 29(6):809-815. PubMed ID: 27015900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dual renin-angiotensin system blockade for nephroprotection.
    Ruggenenti P
    Nephrol Ther; 2017 Apr; 13 Suppl 1():S43-S45. PubMed ID: 28577742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reporting of the estimated glomerular filtration rate was associated with increased use of angiotensin-converting enzyme inhibitors and angiotensin-II receptor blockers in CKD.
    Jain AK; Cuerden MS; McLeod I; Hemmelgarn B; Akbari A; Tonelli M; Quinn RR; Oliver MJ; Garg AX
    Kidney Int; 2012 Jun; 81(12):1248-53. PubMed ID: 22437415
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Nephroprotection by inhibition of the renin-angiotensin system--wish or reality?].
    Barnas U; Mayer G
    Wien Klin Wochenschr; 1995; 107(1):10-4. PubMed ID: 7871784
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors of the renin-angiotensin system reduce the rate of GFR decline and end-stage renal disease in patients with severe renal insufficiency.
    Pisoni R; Faraone R; Ruggenent P; Remuzzi G
    J Nephrol; 2002; 15(4):428-30. PubMed ID: 12243375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renin-angiotensin system blockade alone or combined with ET
    Sedláková L; Čertíková Chábová V; Doleželová Š; Škaroupková P; Kopkan L; Husková Z; Červenková L; Kikerlová S; Vaněčková I; Sadowski J; Kompanowska-Jezierska E; Kujal P; Kramer HJ; Červenka L
    Clin Exp Hypertens; 2017; 39(2):183-195. PubMed ID: 28287881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of and risk factors for severe acute kidney injury in children with heart failure treated with renin-angiotensin system inhibitors.
    Terano C; Ishikura K; Miura M; Hamada R; Harada R; Sakai T; Hamasaki Y; Hataya H; Ando T; Honda M
    Eur J Pediatr; 2016 May; 175(5):631-7. PubMed ID: 26687571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of ACE inhibitors on coronary atherosclerosis and restenosis.
    Timmis AD; Pitt B
    Br Heart J; 1994 Sep; 72(3 Suppl):S57-60. PubMed ID: 7946805
    [No Abstract]   [Full Text] [Related]  

  • 20. Combined blockade of the renin-angiotensin system with angiotensin-converting enzyme inhibitors and angiotensin II type 1 receptor antagonists.
    Azizi M; Ménard J
    Circulation; 2004 Jun; 109(21):2492-9. PubMed ID: 15173039
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.